You have seen the morning show segments. A grave-looking anchor shakes his head at the camera while a doctor scolds men for skipping their routine health screenings. The narrative is always the exact same: Men are stubborn, men are too macho to visit the clinic, and their refusal to endure a simple blood test or physical exam is sending them to early graves.
It is a neat, emotionally manipulative narrative. It is also scientifically illiterate.
The poster child for this medical guilt trip is the PSA (Prostate-Specific Antigen) test, often paired with the dreaded digital rectal exam. For decades, the medical establishment bullied men over fifty into an annual PSA draw. We were told this was the absolute gold standard for catching prostate cancer early. We were told it saves lives.
The reality of routine prostate cancer screening is far darker. By blindly agreeing to the traditional screening protocol, millions of men step onto a medical conveyor belt that leads straight to unnecessary surgical complications, permanent impotence, and urinary incontinence.
Richard Ablin discovered the prostate-specific antigen in 1970. Decades later, he publicly condemned the routine screening of asymptomatic men, calling the widespread use of his own discovery a "profit-driven public health disaster."
When the inventor of the test begs the medical community to stop abusing it, you should listen.
The Anatomy of a False Alarm
The fundamental flaw in the lazy consensus surrounding men's health tests is a misunderstanding of what the PSA test actually measures.
PSA is not a cancer test. It is a protein produced by the prostate gland. Elevated levels simply mean the prostate is agitated. What agitates a prostate? Almost anything. Riding a bicycle can spike your PSA. A recent ejaculation can spike your PSA. Benign prostatic hyperplasia (BPH)—a normal enlargement of the gland that happens to nearly every aging man—spikes your PSA. A minor, asymptomatic urinary tract infection will send your numbers through the roof.
Yet, primary care physicians routinely pull this blood panel during an annual physical without a second thought. When the number comes back at 4.5 ng/mL, the doctor panics. The doctor then passes that panic onto you.
You are immediately referred to a urologist. The trap has been sprung.
The Biopsy Cascade
This is where the real harm begins. Instead of waiting, retesting, or looking at the broader clinical picture, the traditional urological reflex is to perform a transrectal ultrasound (TRUS) guided biopsy.
This procedure involves firing twelve to fourteen spring-loaded needles through the rectal wall and into the prostate gland to hunt for malignant cells. It is exactly as barbaric as it sounds. Because the needles pass through the rectum, the procedure carries a significant risk of severe infection and sepsis, even with prophylactic antibiotics.
Imagine a scenario where your PSA was elevated because you rode a Peloton the morning of your blood test. Three weeks later, you are sitting in an emergency room with a fever of 103°F, battling a life-threatening blood infection caused by a needle biopsy that was never medically necessary.
This happens to thousands of men every single year. The daytime talk shows conveniently leave this out of their cheerful public service announcements.
The Illusion of Saving Lives
Let us assume you survive the biopsy without infection. The pathologist looks at the tissue and finds cancer.
You hear the "C" word and the world stops spinning. Your doctor discusses surgical dates. You are terrified, so you agree to the operation. You endure a radical prostatectomy. You spend months recovering. You pat yourself on the back for catching it early. You think the test saved your life.
The clinical data tells a completely different story.
Most prostate cancers found through routine PSA screening are what pathologists grade as Gleason 3+3=6. This is an extremely slow-growing, indolent tumor. In the pathological community, there is an ongoing, fierce debate about whether Gleason 6 should even be legally classified as "cancer" because it lacks the molecular machinery to metastasize and kill you. It acts more like a gray hair than a deadly tumor. It is simply a byproduct of aging.
Autopsy studies routinely show that the vast majority of men over the age of 80 die with prostate cancer, not of it. They died of heart attacks, strokes, or old age, completely unaware they harbored mutated cells in their prostate.
When doctors screen everyone, they find millions of these harmless, slow-growing tumors. Because the medical and legal systems are terrified of liability, these doctors treat indolent tumors aggressively. This phenomenon is called overdiagnosis, and it leads directly to the slaughterhouse of overtreatment.
The Butcher's Bill
Treating a cancer that was never going to harm you is not a victory. It is a tragedy.
The prostate is a walnut-sized gland buried deep in the pelvis, surrounded by a microscopic web of nerves responsible for erectile function. The sphincter that controls your bladder sits just below it.
Even with the most advanced robotic-assisted surgical systems, removing the prostate or blasting it with radiation often causes catastrophic collateral damage. A massive percentage of men who undergo radical prostatectomies for low-risk prostate cancer wake up with permanent erectile dysfunction. Many lose bladder control and spend the rest of their lives wearing adult diapers.
You trade your sex life and your dignity to eradicate a tumor that would have taken forty years to grow an inch. The urology clinic bills your insurance for $40,000. Everyone wins except you.
The UK-based ProtecT trial tracked men with localized prostate cancer for over a decade. They compared men who got surgery, men who got radiation, and men who did absolutely nothing but monitor the cancer. The 10-year survival rate for the men who did nothing was 99%.
You are being rushed into the operating room for a disease you can likely just watch.
Redefining the Right Questions
If you search the internet for advice on this topic, you will find a list of frequently asked questions rooted in outdated medical dogma. Stop asking the wrong questions.
"At what age should men start getting a prostate exam?"
This question assumes a blanket rule applies to all biology. A better question is: Based on my baseline risk, do I need prostate screening at all? If you are a 72-year-old man with no symptoms, getting a routine PSA test is statistically one of the most dangerous things you can do to your quality of life. The United States Preventive Services Task Force (USPSTF) literally recommends against screening men over 70 for this exact reason.
"What are the symptoms of high PSA?"
There are none. PSA is a microscopic protein. The lack of symptoms is exactly why routine screening creates so much blind anxiety. If you have trouble urinating, that is usually BPH, not cancer.
The Bitter Pill of the Contrarian Approach
I have watched men lose their marriages and their mental health over the side effects of unnecessary prostate surgeries. But I must be brutally honest about the flip side of this coin.
If you completely abandon all screening and you happen to be the rare, unlucky man harboring an aggressive Gleason 8 or 9 tumor, you will miss the window for a cure. Aggressive prostate cancer that metastasizes to the bones is an agonizing, horrific way to die.
The solution to a flawed screening system is not willful ignorance. The solution is precision. You must reject the lazy conveyor belt and take control of the logistics.
The Actual Lifesaving Playbook
Stop skipping the doctor, but stop saying yes to every automated test they throw at you. Here is the clinical protocol you should actually follow to protect your life without sacrificing your manhood.
1. Determine Your Real Baseline Risk
Risk stratification is everything. If you are African American, or if you have a primary relative (father or brother) who died of aggressive prostate cancer, the standard rules do not apply to you. You are in a high-risk category. You need early, strict surveillance starting at age 40.
2. Establish a Baseline, Then Stop Panicking
For average-risk men, get a baseline PSA test at age 45 or 50. If the number is incredibly low (e.g., under 1.0 ng/mL), your risk of developing lethal prostate cancer over the next decade is close to zero. You do not need this test every single year. Space it out to every three to five years.
3. Demand the MRI
If your PSA comes back elevated, absolutely refuse an immediate blind TRUS biopsy. Tell your urologist you want a multiparametric MRI (mpMRI) of the prostate first.
This is the non-negotiable step the morning shows ignore. An mpMRI allows radiologists to look directly at the prostate. If the MRI shows no suspicious lesions, you do not need a biopsy. You just watch the PSA. If the MRI does show a suspicious lesion (graded via the PI-RADS system), the urologist can perform a targeted biopsy, aiming the needle directly at the tumor rather than firing blindly into your rectum and hoping for the best.
4. Embrace Active Surveillance
If a targeted biopsy finds a low-grade Gleason 6 cancer, do not rush to the operating table. Seek out a major academic medical center and enroll in an active surveillance program. You will get periodic MRIs and blood tests to ensure the tumor isn't mutating. You keep your prostate. You keep your erections. You keep your bladder control. You wait until the tumor actually proves it is a threat before you draw your sword.
The medical system thrives on your fear. It profits from your compliance. The next time a doctor hands you a lab slip for a routine, uncontextualized PSA draw, ask them what their protocol is for an elevated result. If their first answer is a blind biopsy, walk out of the clinic.
Cancel the blind biopsy. Demand the MRI. Protect your quality of life.
